Works matching DE "DUPILUMAB"

Results: 1198

A Clinician's Guide to Dupilumab-related Ocular Surface Disease.

Published in:

Journal of Clinical & Aesthetic Dermatology, 2025, v. 18, n. 5, p. 26

By:

ASSAF, SANDI;
LIO, PETER;
DEL ROSSO, JAMES Q.

Publication type:

Article

Double dose of dupilumab shows efficacy in treatment-resistant bullous pemphigoid.

Published in:

Clinical & Experimental Dermatology, 2025, v. 50, n. 6, p. 1211, doi. 10.1093/ced/llaf002

By:

Mills, Kaitlyn;
Maarouf, Melody

Publication type:

Article

Increased prevalence of dysphagia in patients with severe atopic dermatitis candidates for biological therapy: implications for diagnosis and management of type 2-related disorders.

Published in:

Clinical & Experimental Dermatology, 2025, v. 50, n. 6, p. 1209, doi. 10.1093/ced/llaf001

By:

Napolitano, Maddalena;
Pesce, Marcella;
Potestio, Luca;
Patruno, Cataldo;
Cecere, Daniele;
Ricchiuti, Mario;
Cefaliello, Antonio;
Sarnelli, Giovanni

Publication type:

Article

Refractory lichen planus: success with dupilumab.

Published in:

Clinical & Experimental Dermatology, 2025, v. 50, n. 6, p. 1204, doi. 10.1093/ced/llae425

By:

Read, Madison H;
Swain, Elizabeth;
Lovell, Katie K;
Feldman, Steven R

Publication type:

Article

Mycosis fungoides and IL-4/13 inhibitors: what is known and unmet needs.

Published in:

Expert Review of Clinical Immunology, 2025, v. 21, n. 6, p. 723, doi. 10.1080/1744666X.2025.2507332

By:

Guglielmo, Alba;
Borghi, Alessandro;
Schettini, Natale;
Perillo, Marcello;
Corazza, Monica;
Piraccini, Bianca Maria;
Pileri, Alessandro

Publication type:

Article

Dupilumab Outperforms Omalizumab in First Head-to-Head Respiratory Study for CRSwNP with Comorbid Asthma.

Published in:

2025

By:

Halsey, Grace

Publication type:

Abstract

Dupilumab Outperforms Omalizumab in First Head-to-Head Respiratory Study for CRSwNP with Comorbid Asthma.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Dupilumab treatment has no effect on the nasal microbiome in patients with NSAID-exacerbated respiratory disease: a longitudinal pilot study.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1508500

By:

Bartosik, Tina;
Pjevac, Petra;
Séneca, Joana;
Morgenstern, Christina;
Arnoldner, Tamara;
Gangl, Katharina;
Sinz, Christoph;
Campion, Nicholas James;
Tu, Aldine;
Stanek, Victoria;
Bangert, Christine;
Schneider, Sven;
Eckl-Dorna, Julia

Publication type:

Article

Dupilumab-Induced Remission in Chronic Rhinosinusitis with Nasal Polyps and Comorbid Asthma: A 24-Month Study.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 11, p. 3654, doi. 10.3390/jcm14113654

By:

Tajiri, Tomoko;
Suzuki, Motohiko;
Nishiyama, Hirono;
Ozawa, Yoshiyuki;
Amakusa, Yuki;
Suzuki, Tatsuro;
Ito, Keima;
Mori, Yuta;
Fukumitsu, Kensuke;
Fukuda, Satoshi;
Kanemitsu, Yoshihiro;
Uemura, Takehiro;
Ohkubo, Hirotsugu;
Takemura, Masaya;
Ito, Yutaka;
Oguri, Tetsuya;
Niimi, Akio

Publication type:

Article

Evaluation of Small Airways Dysfunction With Dupilumab Using Airway Oscillometry in Uncontrolled Severe Asthma.

Published in:

Clinical & Experimental Allergy, 2025, v. 55, n. 3, p. 264, doi. 10.1111/cea.70002

By:

Stewart, Kirsten E.;
Kuo, Chris RuiWen;
Chan, Rory;
Lipworth, Brian J.

Publication type:

Article

Relationship Between Bronchodilator Reversibility and Spirometry Response to Dupilumab in Type 2 High Uncontrolled Severe Asthma.

Published in:

Clinical & Experimental Allergy, 2025, v. 55, n. 3, p. 253, doi. 10.1111/cea.14634

By:

Greig, Robert;
Stewart, Kirsten;
Kuo, Chris RuiWen;
Chan, Rory;
Lipworth, Brian

Publication type:

Article

Dupilumab for Atopic Dermatitis with Twenty-Nail Dystrophy: A Case Report.

Published in:

2025

By:

Li, Ji;
Zhang, Duo;
Dong, Shuying;
Zhu, Lili;
Li, Xiaodong;
Han, Yang

Publication type:

Case Study

Dupilumab Sustains Long-Term Reduction of Staphylococcus aureus in Patients with Atopic Dermatitis.

Published in:

2025

By:

Jennings, Sydney

Publication type:

Abstract

Dupilumab Monotherapy Improves AD Severity and Pigmentation in People With Skin of Color.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Dupilumab Sustains Long-Term Reduction of Staphylococcus aureus in Patients with Atopic Dermatitis.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Dupilumab Monotherapy Improves AD Severity and Pigmentation in People With Skin of Color.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Dupilumab Sustains Long-Term Reduction of Staphylococcus aureus in Patients with Atopic Dermatitis.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Clinical effectiveness of dupilumab in CRSwNP: unaffected by baseline nasal polyp size in real-world settings.

Published in:

European Archives of Oto-Rhino-Laryngology, 2025, v. 282, n. 6, p. 3329, doi. 10.1007/s00405-025-09275-2

By:

Habenbacher, Michael;
Moser, Ulrich;
Abaira, Ahmed;
Kiss, Peter;
Holzmeister, Clemens;
Pock, Jakob;
Walla, Katharina;
Lang, Angelika;
Andrianakis, Alexandros

Publication type:

Article

Correlation Between Smell Recovery and Nasal Polyp Score in Patients Treated with Dupilumab: A Real-Life Retrospective, Observational, Monocentric Study.

Published in:

Journal of Personalized Medicine, 2025, v. 15, n. 5, p. 164, doi. 10.3390/jpm15050164

By:

Stilo, Giovanna;
Messina, Giuliano;
Lo Faro, Carmelo;
Ruta, Sara;
Frangipane, Silvia;
Mariut, Diana;
Giunta, Giorgia;
Distefano, Maria Elvira;
Zappalà, Andrea Guglielmo;
Maniaci, Antonino;
Bianchi, Alberto;
La Mantia, Ignazio

Publication type:

Article

Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis.

Published in:

Medicina (1010660X), 2025, v. 61, n. 5, p. 926, doi. 10.3390/medicina61050926

By:

Horie, Akihiro;
Miyagaki, Tomomitsu;
Hiranuma, Chikako;
Iijima, Mami;
Hara, Yoshiaki;
Oba, Shinya;
Hashimoto, Mina;
Omori, Reina;
Okano, Tatsuro;
Kadono, Takafumi

Publication type:

Article

Super Responders in Moderate-to-Severe Atopic Dermatitis Under Treatment with Dupilumab: An Explorative Real-World Study.

Published in:

Journal of Clinical Medicine, 2025, v. 14, n. 10, p. 3480, doi. 10.3390/jcm14103480

By:

Mastorino, Luca;
Mendes-Bastos, Pedro;
Cavaliere, Giovanni;
Siliquini, Niccolo;
Ortoncelli, Michela;
Quaglino, Pietro;
Ribero, Simone

Publication type:

Article

Dupilumab‐Associated Ocular Surface Disease in Pediatric Atopic Dermatitis: A Single‐Center Asian Experience.

Published in:

Pediatric Dermatology, 2025, v. 42, n. 3, p. 481, doi. 10.1111/pde.15814

By:

Yap, Amanda Xin Yi;
Tan, Deborah;
Koh, Mark Jean‐Aan;
Yang, Lin Yi;
Zhe, Koh Yi;
Wee, Lynette Wei‐Yi

Publication type:

Article

Long-Term Real-World Outcomes and Insights of Biologic Therapies in Chronic Rhinosinusitis with Nasal Polyps.

Published in:

International Journal of Molecular Sciences, 2025, v. 26, n. 10, p. 4694, doi. 10.3390/ijms26104694

By:

Book, Reut;
Lazutkin, Anna;
Eliashar, Ron

Publication type:

Article

Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study.

Published in:

Dermatology (10188665), 2025, v. 241, n. 1, p. 10, doi. 10.1159/000542275

By:

Thyssen, Jacob P.;
Rosmarin, David;
Costanzo, Antonio;
Warren, Richard;
Chu, Chia-Yu;
Chovatiya, Raj;
Ladizinski, Barry;
Hu, Xiaofei;
Liu, Yingyi;
Calimlim, Brian;
Nduaka, Chudi;
Vigna, Namita;
Armstrong, April

Publication type:

Article

Fast Itch Relief during Dupilumab Predicts Clinical Efficacy in Bullous Pemphigoid: A Retrospective Cohort Study.

Published in:

Dermatology (10188665), 2024, v. 240, n. 5/6, p. 694, doi. 10.1159/000540590

By:

Thevan, Jeivicaa;
Schmauch, Eloi;
Nilsson, Jakob;
Guillet, Carole Florence;
Boesch, Andrea;
Krähenbühl, Lukas;
Meier-Schiesser, Barbara;
Schmid-Grendelmeier, Peter;
Kündig, Thomas;
Kolios, Antonios G.A.

Publication type:

Article

Efficacy and Safety of Dupilumab in Chinese Elderly Patients with Atopic Dermatitis: A Real-World Study.

Published in:

Dermatology (10188665), 2024, v. 240, n. 4, p. 589, doi. 10.1159/000539355

By:

Hu, Yu-Qing;
Zhang, Jian-Zhong;
Zhao, Yan

Publication type:

Article

Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study.

Published in:

Dermatology (10188665), 2024, v. 240, n. 2, p. 337, doi. 10.1159/000535282

By:

Berna-Rico, Emilio;
Fiz-Benito, Esther;
Busto-Leis, Jose Manuel;
Servera-Negre, Guillermo;
de Lucas-Laguna, Raul;
Feito-Rodriguez, Marta

Publication type:

Article

Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life.

Published in:

Dermatology (10188665), 2023, v. 239, n. 5, p. 811, doi. 10.1159/000531708

By:

Richter, Clara;
Hafner, Jürg;
Schuermann, Manuel;
Tanadini, Matteo;
Trisconi, Nisia;
Schmid-Grendelmeier, Peter;
Kündig, Thomas;
Nägeli, Mirjam;
Brüggen, Marie-Charlotte;
Guillet, Carole

Publication type:

Article

Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review.

Published in:

Dermatology (10188665), 2023, v. 239, n. 4, p. 646, doi. 10.1159/000530608

By:

Su, Zheng;
Zeng, Yue-Ping

Publication type:

Article

Successful Treatment of Prurigo Nodularis by Dupilumab: Report of 24 Patients.

Published in:

Dermatology (10188665), 2023, v. 239, n. 4, p. 658, doi. 10.1159/000529965

By:

Gao, Zirui;
Dou, Yuanqing;
Zhao, Pei;
Wang, Caroline J;
Zhang, Jianzhong

Publication type:

Article

Efficacy and Safety of Multiple Dupilumab Dose Regimens in Patients with Moderate-To-Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Published in:

Dermatology (10188665), 2022, v. 238, n. 6, p. 1060, doi. 10.1159/000524608

By:

Shih, Ya-Chu;
Yeh, Marvin Chia-Han;
Yang, Fu-An;
Chen, Hung-Chou

Publication type:

Article

Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case Series.

Published in:

Dermatology (10188665), 2023, v. 239, n. 1, p. 72, doi. 10.1159/000525987

By:

Ragamin, Aviël;
Nouwen, Anouk E.M.;
Dalm, Virgil A.S.H.;
van Mierlo, Minke M.F.;
Lincke, Carsten R.;
Pasmans, Suzanne G.M.A.

Publication type:

Article

Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series.

Published in:

Dermatology (10188665), 2022, v. 238, n. 6, p. 1073, doi. 10.1159/000524380

By:

Slodownik, Dan;
Levi, Assi;
Lapidoth, Moshe;
Moshe, Shlomo

Publication type:

Article

Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients.

Published in:

Dermatology (10188665), 2022, v. 238, n. 4, p. 717, doi. 10.1159/000519361

By:

Chiricozzi, Andrea;
Gori, Niccolò;
Di Nardo, Lucia;
Antonelli, Flaminia;
Caruso, Cristiano;
Caldarola, Giacomo;
Calabrese, Laura;
Guerriero, Cristina;
De Simone, Clara;
Peris, Ketty

Publication type:

Article

Successful Combination of Systemic Agents for the Treatment of Atopic Dermatitis Resistant to Dupilumab Therapy.

Published in:

Dermatology (10188665), 2021, v. 237, n. 4, p. 535, doi. 10.1159/000512890

By:

Gori, Niccolò;
Chiricozzi, Andrea;
Malvaso, Dalma;
D'Urso, Dario Francesco;
Caldarola, Giacomo;
De Simone, Clara;
Peris, Ketty

Publication type:

Article

Biological Therapies for Atopic Dermatitis: A Systematic Review.

Published in:

Dermatology (10188665), 2021, v. 237, n. 4, p. 542, doi. 10.1159/000514535

By:

Zhou, Shuying;
Qi, Fei;
Gong, Yue;
Zhang, Jinping;
Zhu, Binghua

Publication type:

Article

Dupilumab and Alopecia: Causative or Therapeutic?

Published in:

2019

By:

Hendricks, Aleksi J.;
Lio, Peter A.;
Shi, Vivian Yan;
Hendricks, Aleksi J;
Lio, Peter A;
Shi, Vivian Yan

Publication type:

journal article

Dupilumab Approved for Uncontrolled Chronic Spontaneous Urticaria: Daily Dose.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

New Data on Dupilumab Reinforces Its Impact on Chronic Respiratory Diseases.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Dupilumab Effective, Safe for Severe Pediatric Atopic Dermatitis: Daily Dose.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Emerging Therapies Show Potential for Hard-to-Treat Chronic Spontaneous Urticaria.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

FDA Approves Dupilumab for Chronic Spontaneous Urticaria Uncontrolled by Antihistamines.

Published in:

2025

By:

Jennings, Sydney

Publication type:

Case Study

Dupilumab is Safe and Effective Across Pediatric Populations with Severe Atopic Dermatitis: New Meta-Analysis.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Dupilumab Found Beneficial in COPD with Type 2 Inflammation: Daily Dose.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Jennings, Sydney

Publication type:

Article

Dupilumab Demonstrates Superior Long-Term Persistence Over Upadacitinib and Tralokinumab in Atopic Dermatitis.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Upadacitinib Demonstrates Superior Regional, Overall Efficacy vs Dupilumab in Atopic Dermatitis: Level Up Phase 3b/4 Trial Findings.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Lebrikizumab Improves Patient-Reported Outcomes in Atopic Dermatitis for Patients Previously Treated with Dupilumab.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Dupilumab Demonstrates Superior Long-Term Persistence Over Upadacitinib and Tralokinumab in Atopic Dermatitis.

Published in:

Patient Care (Online), 2025, p. N.PAG

By:

Halsey, Grace

Publication type:

Article

Lebrikizumab Improves Patient-Reported Outcomes in Atopic Dermatitis for Patients Previously Treated with Dupilumab.

Published in:

2025

By:

Halsey, Grace

Publication type:

Case Study

Dupilumab Shows Efficacy and Safety in COPD With Type 2 Inflammation: AAAAI 2025.

Published in:: Patient Care (Online), 2025, p. N.PAG
Publication type:: Article